Biofilms and chronic infections

JAMA

Volumn 299, Issue 22, 2008, Pages 2682-2684

  Wolcott, Randall D ^a   Ehrlich, Garth D ^b,c  

^a Medical Biofilm Research Institute Lubbock   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT;

BACTERIAL INFECTION; BIOFILM; DISEASE SEVERITY; FLUORESCENCE IN SITU HYBRIDIZATION; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MICROBIAL COMMUNITY; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ARTICLE; BACTERIUM ADHERENCE; CHRONIC DISEASE; PATHOPHYSIOLOGY;

BACTERIAL ADHESION; BIOFILMS; CHRONIC DISEASE; HUMANS; INFECTION;

EID: 44949093604     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.22.2682     Document Type: Note

References (13)

1. The Official Web Site of the Nobel Foundation 2007 [cited August 8, 2007]. Robert Koch The Nobel Prize in Physiology or Medicine 1905. http://nobelprize.org/nobel_prizes/medicine/laureates/1905/koch-bio.html. Accessed May 16, 2008.
2. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am. 1978;238(1):86-95.
3. El-Azizi M, Rao S, Kanchanapoom T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob. 2005;4:2.
4. Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC. Bacterial plurality as a general mechanism driving persistence in chronic infections. Clin Orthop Relat Res. 2005;(437):20-24.
5. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47(1):317-323.
6. Prince AS. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med. 2002;347(14):1110-1111.
7. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 2008;8:43.
8. Geesey GG, Richardson WT, Yeomans HG, Irvin RT, Costerton JW. Microscopic examination of natural sessile bacterial populations from an alpine stream. Can J Microbiol. 1977;23(12):1733-1736.
9. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 2003;112(10):1466-1477.
10. Blumenfeld TJ, Bargar WL. Early aseptic loosening of a modern acetabular component secondary to a change in manufacturing. J Arthroplasty. 2006;21(5):689-695.
11. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19(1):165-256.
12. SBIR/STTR Study and Control of Microbial Biofilms. http://grants.nih.gov/ grants/guide/pa-files/PA-99-084.html. Released April 21, 1999. Accessed May 16, 2008.
13. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5(1):48-56.